Thursday, 18 May 2017
FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer
Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show clinical benefit in patients with liver metastases originating from difficult-to-treat right-sided colon cancer The FOXFIRE Combined Analysis was a study of 1,103 patients randomised to receive either...
Wednesday, 10 May 2017
100km non-stop in 24 hours
Five members of Professor Len Seymour's laboratory (Arthur Dyer, Sally Frost, Sophie Owen, Tzveta Pokrovska and Ellie Scott) are limbering up to walk 100km non-stop in 24 hours over the August bank holiday to raise money for Cancer Research UK, Martlet's Hospice and the Red Cross. If you have any...
Friday, 5 May 2017
Video makers visit the Department of Oncology
Last September, a challenge went out to schools to make a two-minute video to explain our science to the public. Over 30 teams of students rose to the challenge. On 5 April, the top six entries visited the Department of Oncology to collect their prizes and take advantage of the opportunity to...
Monday, 10 April 2017
2016 Oxford Harrington Scholarship
It was announced in August 2016 that Professor Valentine Macaulay was awarded the 2016 Oxford Harrington Scholarship. Professor Macaulay’s work focuses on understanding growth factor receptor function, and the award was given to support novel approaches to disrupt receptor function as therapy for...
Friday, 7 April 2017
Cancer Research UK Boat Race
Joshua Bugajski (Stroke 4), an MSc Oncology student in Katherine Vallis’ group was part of Oxford’s winning team on Sunday, 2 April when they cruised to victory in the 2017 Cancer Research UK boat race against Cambridge. Oxford won the toss and chose the Surrey station. The crew took an early...
Monday, 27 March 2017
New era in precision medicine for pancreatic cancer
The development of new treatments for pancreatic cancer is set to be transformed by a network of pancreatic clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK announced today. The investment will support the PRECISION Panc...
Thursday, 23 March 2017
A big thank you to the Natural History Museum in Oxford for again giving us a chance to show off our science on Saturday, 11 March. They tolerated a lot of mess as we enterained our visitors with some ideas from Professor Sibson who is developing ways to make brain tumours more accessible to...
Friday, 17 March 2017
Oxfordshire Apprenticeship Awards
The inaugural Oxfordshire Apprenticeship Awards recognised the best talent in the county at a presentation evening on Wednesday, 8 March at the Marlborough Enterprise Centre in Woodstock during the 10th National Apprenticeship Week. These new awards enabled Oxfordshire Apprenticeships to celebrate...
Friday, 10 March 2017
Super Science Saturday: curing the brain
Visit the Oxford University Museum of Natural History and explore science surrounded by dinosaurs! On Saturday 11 March, members of the Department of Oncology will be exploring how the brain presents special challenges in cancer research. They will be highlighting the work of Professor Nicola...
Wednesday, 1 March 2017
Girls do physics: physics cures cancer
In late February the Department of Physics hosted a Greenlight for Girls event to encourage young women to think about studying physics and to challenge the perception that physics is for boys. The Department of Oncology joined the workshop which highlighted the impact of physics in the treatment...
Monday, 13 February 2017
Viruses killing cancer cells: stimulating an immune response within the cancer microenvironment
Using funding from CRUK and Psioxus Therapeutics, a team of researchers from the University of Oxford led by Professor Len Seymour, have recently published a paper in Molecular Therapy Oncolytics. Researchers from the Department of Oncology have been working on creating a therapeutic virus that can...
Monday, 12 December 2016
Bubbles, ultrasound and radiotherapy: creating a new approach to drug delivery
Using funding from the CRUK–EPSRC Multidisciplinary Project Award, a team of researchers from the University of Oxford, Clinical Oncologist Professor Anne Kiltie, Biomedical Engineer Professor Eleanor Stride and Biophyscist Professor Boris Vonjovic, are sharing their respective expertise to unlock...
Friday, 9 December 2016
2016 Advanced Apprenticeship Award
Workshop Apprentice Kyle Hallett, has been awarded the 2016 Advanced Apprentice Award at the University of Oxford’s 2016 Apprenticeship Awards which was held at the Sheldonian on Friday, 9 December. The award has recognised Kyle’s huge amount of enthusiasm for learning all aspects of work. He has...
Thursday, 17 November 2016
A new DNA repair pathway discovery by the Ramadan group
Members from Kristijan Ramadan’s group in the CRUK/MRC Oxford Institute of Radiation Oncology have discovered a mechanism of how cells remove covalently attached proteins from DNA, known as DNA-protein crosslinks (DPCs). DPCs are toxic lesions and if they are not removed lead to genomic...
Tuesday, 8 November 2016
Gold nanoparticles help deliver lethal one-two punch to cancer
Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug right into the heart of cancer cells, according to new laboratory research being presented at the 2016 National Cancer Research Institute (NCRI) Cancer conference....
Monday, 31 October 2016
University of Oxford researchers awarded more than £140,000 to develop new techniques to detect pancreatic cancer
Thursday, 1 September 2016
Oxford Researcher awarded nearly £1m to explore potential "game changing" treatment for prostate cancer
Thursday, 21 July 2016
Congratulations to our new Professors, Associate Professors and University Research Lecturers
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.